EUVIMEDEUVIMED entdecken
Crossref

P65‐Driven MIR4435‐2HG Enhances Prognostic Value and Mediates Oxaliplatin Resistance via the miR‐378G/ABCB9 Axis in Colorectal Cancer

Xiaopeng Zhuang, Jinji Jin, Jun Cheng, Zhejing Chen, Weijian Zhu, Xielin Huang, Jiancheng Sun, Chengyin Lin, Qiantong Dong, Dongwang Yan, Xiaoliang Qi iD, Wenyi Wu

Macromolecular Bioscience · 2025-10 · 25 (10)

DOI: 10.1002/mabi.202400663 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 10.06.2025. Verfasst von Xiaopeng Zhuang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, Zhejiang, C…. Hauptthemen laut MEDLINE: Oxaliplatin, MicroRNAs, Colorectal Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Special Fund of Zhejiang Upper Gastrointestinal Tumor Diagnosis and Treatment Technology Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long non‐coding RNA MIR4435‐2HG has emerged as a pivotal oncogenic factor across various cancers. However, its role in chemoresistance, particularly in colorectal cancer (CRC), remains unclear. This work demonstrates that MIR4435‐2HG is significantly overexpressed in CRC tissues, correlating with poor prognosis and resistance to oxaliplatin (L‐OHP) based chemotherapy. Mechanistically, MIR4435‐2HG binds to miR‐378g, leading to elevated ABCB9 levels, a crucial factor in drug resistance. Both in vitro and in vivo experiments indicate that the MIR4435‐2HG/miR‐378g/ABCB9 axis confers L‐OHP resistance in CRC cells by reducing DNA damage and enhancing cell survival. Additionally, P65, a component of the NF‐κB pathway, directly promotes MIR4435‐2HG transcription, triggering subsequent chemoresistance. Based on these results, MIR4435‐2HG is recognized as a reliable prognostic marker and serves as a target for therapeutic strategies, presenting new approaches to counteract L‐OHP resistance and enhance CRC patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxaliplatinMicroRNAsColorectal NeoplasmsDrug Resistance, NeoplasmTranscription Factor RelAHumansPrognosisGene Expression Regulation, NeoplasticAnimalsFemaleCell Line, TumorMaleMiceMice, Nude

Stichwörter der Autor:innen

ABCB9L‐OHPMIR4435‐2HGcolorectal cancermiR‐378gresistance

Substanzen

OxaliplatinMicroRNAsTranscription Factor RelAMIRN378 microRNA, humanRELA protein, human

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Central Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID-Profile: Xiaoliang Qi

Förderung

  • National Natural Science Foundation of China
  • Special Fund of Zhejiang Upper Gastrointestinal Tumor Diagnosis and Treatment Technology Research Center

Zitieren

APA

Zhuang, X., Jin, J., Cheng, J., Chen, Z., Zhu, W., Huang, X., Sun, J., Lin, C., Dong, Q., Yan, D., Qi, X., & Wu, W. (2025). P65‐Driven MIR4435‐2HG Enhances Prognostic Value and Mediates Oxaliplatin Resistance via the miR‐378G/ABCB9 Axis in Colorectal Cancer. Macromolecular Bioscience, 25(10). https://doi.org/10.1002/mabi.202400663

Vancouver

Zhuang X, Jin J, Cheng J, Chen Z, Zhu W, Huang X, et al. P65‐Driven MIR4435‐2HG Enhances Prognostic Value and Mediates Oxaliplatin Resistance via the miR‐378G/ABCB9 Axis in Colorectal Cancer. Macromolecular Bioscience. 2025;25(10). doi:10.1002/mabi.202400663

BibTeX
@article{Zhuang2025,
  author = {Zhuang, Xiaopeng and Jin, Jinji and Cheng, Jun and Chen, Zhejing and Zhu, Weijian and Huang, Xielin and Sun, Jiancheng and Lin, Chengyin and Dong, Qiantong and Yan, Dongwang and Qi, Xiaoliang and Wu, Wenyi},
  title = {P65‐Driven MIR4435‐2HG Enhances Prognostic Value and Mediates Oxaliplatin Resistance via the miR‐378G/ABCB9 Axis in Colorectal Cancer},
  journal = {Macromolecular Bioscience},
  year = {2025},
  volume = {25},
  number = {10},
  doi = {10.1002/mabi.202400663}
}
Kostenlos starten →